COMP <GO>
IMMX vs DSGN // OPERATING MARGIN
Immix Biopharma Inc. (NASDAQ) VS. Design Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IMMX 1
— DSGN 3
■ METRIC PARITY
LAST: $7.26 (-5.47%) • MKT CAP: $636.7M
operating-margins
—
LAST: $10.15 (-4.96%) • MKT CAP: $668.4M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMMX VS. DSGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMMX | DSGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -32.10% | -2.90 | DSGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.73% | -7.88% | +4.15 | IMMX | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 26.00 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.8 | 43.3 | -10.50 | DSGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $636.7M | $668.4M | -$31.7M | DSGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMMX REV | DSGN REV | IMMX GROSS % | DSGN GROSS % | IMMX FCF | DSGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $83.9M | $222.5M | — | — | -$24.7M | -$54.6M |
| FY 2024 | $63.5M | $174.7M | — | — | -$15.8M | -$43.4M |
| FY 2023 | $45.2M | $218.9M | — | — | -$11.4M | -$58.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMMX // BETA —
DSGN // BETA —